Mimedx (MDXG) Other Non-Current Assets (2010 - 2026)
Mimedx recorded quarterly Other Non-Current Assets of $6.9 million in Q1 2026, down 5.33% quarter-over-quarter from $7.3 million in Q4 2025, and up 557.06% year-over-year from $1.0 million in Q1 2025.
Mimedx's Other Non-Current Assets history runs 16 years deep, the most recent figure standing at $6.9 million for Q1 2026.
- In Q1 2026, Other Non-Current Assets rose 557.06% year-over-year to $6.9 million; the TTM figure through Mar 2026 stood at $6.9 million (up 557.06% YoY), while the FY2025 annual figure was $7.3 million, up 8.37% from the prior year.
- Other Non-Current Assets came in at $6.9 million for Q1 2026 at Mimedx, down from $7.3 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $7.3 million in Q4 2025 to a low of $146000.0 in Q2 2023.
- A 5-year average of $1.9 million and a median of $1.0 million in 2025 frame the typical range for Other Non-Current Assets.
- Across the five-year window, Other Non-Current Assets slumped 89.01% in 2023 and jumped 3174.15% in 2024, its largest moves.
- Mimedx's Other Non-Current Assets stood at $1.9 million in 2022, then plunged by 89.01% to $205000.0 in 2023, then surged by 3174.15% to $6.7 million in 2024, then grew by 8.37% to $7.3 million in 2025, then fell by 5.33% to $6.9 million in 2026.
- According to Business Quant data, Other Non-Current Assets over the past three periods registered $6.9 million, $7.3 million, and $3.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 12.40 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 60,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.26 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.13 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 63.55 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | 6.89 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 6.89 Mn |
| Dec 31, 2025 | 7.27 Mn |
| Sep 30, 2025 | 2.99 Mn |
| Jun 30, 2025 | 990,000.00 |
| Mar 31, 2025 | 1.05 Mn |
| Dec 31, 2024 | 6.71 Mn |
| Sep 30, 2024 | 1.18 Mn |
| Jun 30, 2024 | 1.24 Mn |
| Mar 31, 2024 | 1.25 Mn |
| Dec 31, 2023 | 205,000.00 |
| Sep 30, 2023 | 149,000.00 |
| Jun 30, 2023 | 146,000.00 |
| Mar 31, 2023 | 147,000.00 |
| Dec 31, 2022 | 1.87 Mn |
| Sep 30, 2022 | 150,000.00 |
| Jun 30, 2022 | 164,000.00 |
| Mar 31, 2022 | 172,000.00 |
| Dec 31, 2021 | 186,000.00 |
| Sep 30, 2021 | 270,000.00 |
| Jun 30, 2021 | 313,000.00 |
| Mar 31, 2021 | 344,000.00 |
| Dec 31, 2020 | 375,000.00 |
| Sep 30, 2020 | 420,000.00 |
| Jun 30, 2020 | 2.23 Mn |
| Mar 31, 2020 | 473,000.00 |
| Dec 31, 2019 | 443,000.00 |
| Sep 30, 2019 | 507,000.00 |
| Jun 30, 2019 | 1.21 Mn |
| Mar 31, 2019 | 1.54 Mn |
| Dec 31, 2018 | 1.79 Mn |
| Dec 31, 2017 | 2.87 Mn |
| Sep 30, 2017 | 3.39 Mn |
| Jun 30, 2017 | 264,000.00 |
| Mar 31, 2017 | 309,000.00 |
| Dec 31, 2016 | 354,000.00 |
| Sep 30, 2016 | 399,000.00 |
| Jun 30, 2016 | 444,000.00 |
| Mar 31, 2016 | 477,000.00 |
| Dec 31, 2015 | 487,000.00 |
| Sep 30, 2015 | 26,000.00 |
| Jun 30, 2015 | 26,000.00 |
| Mar 31, 2015 | 26,000.00 |
| Mar 31, 2013 | 319,545.00 |
| Dec 31, 2012 | 70,000.00 |
| Sep 30, 2012 | 180,428.00 |
| Jun 30, 2012 | 204,803.00 |
| Mar 31, 2012 | 209,595.00 |
| Dec 31, 2011 | 214,342.00 |
| Sep 30, 2011 | 167,257.00 |
| Jun 30, 2011 | 119,082.00 |
| Dec 31, 2010 | 102,500.00 |